Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like Troubled Dimension Therapeutics Sold in All-Stock Deal August 24, 2017 Some GlaxoSmithKline Critics Would Prefer Broke Up the Company July 27, 2017 Human Longevity Co-Founder To Helm Newly Launched Sorrento Spinoff June 12, 2017